Somatic mutations in early onset luminal breast cancer

Giselly Encinas,Veronica Y. Sabelnykova,Eduardo Carneiro de Lyra,Maria Lucia Hirata Katayama,Simone Maistro,Pedro Wilson Mompean de Vasconcellos Valle,Gláucia Fernanda de Lima Pereira,Lívia Munhoz Rodrigues,Pedro Adolpho de Menezes Pacheco Serio,Ana Carolina Ribeiro Chaves de Gouvêa,Felipe Correa Geyer,Ricardo Alves Basso,Fátima Solange Pasini,Maria del Pilar Esteves Diz,Maria Mitzi Brentani,João Carlos Guedes Sampaio Góes,Roger Chammas,Paul C. Boutros,Maria Aparecida Azevedo Koike Folgueira
DOI: https://doi.org/10.18632/oncotarget.25123
2018-04-27
Oncotarget
Abstract:Breast cancer arising in very young patients may be biologically distinct; however, these tumors have been less well studied. We characterized a group of very young patients (≤ 35 years) for BRCA germline mutation and for somatic mutations in luminal (<i>HER2</i> negative) breast cancer. Thirteen of 79 unselected very young patients were <i>BRCA</i>1/2 germline mutation carriers. Of the non-<i>BRCA</i> tumors, eight with luminal subtype (<i>HER2</i> negative) were submitted for whole exome sequencing and integrated with 29 luminal samples from the COSMIC database or previous literature for analysis. We identified C to T single nucleotide variants (SNVs) as the most common base-change. A median of six candidate driver genes was mutated by SNVs in each sample and the most frequently mutated genes were <i>PIK3CA, GATA3, TP53</i> and <i>MAP2K4</i>. Potential cancer drivers affected in the present non-<i>BRCA</i> tumors include <i>GRHL2, PIK3AP1, CACNA1E</i>, <i>SEMA6D</i>, <i>SMURF2</i>, <i>RSBN1</i> and <i>MTHFD2.</i> Sixteen out of 37 luminal tumors (43%) harbored SNVs in DNA repair genes, such as <i>ATR, BAP1, ERCC6, FANCD2, FANCL, MLH1</i>, <i>MUTYH, PALB2, POLD1, POLE</i>, <i>RAD9A, RAD51 and TP53</i>, and 54% presented pathogenic mutations (frameshift or nonsense) in at least one gene involved in gene transcription. The differential biology of luminal early-age onset breast cancer needs a deeper genomic investigation.
What problem does this paper attempt to address?